UT Dallas spinout Cersci has raised approximately $4m to advance its non-opioid painkiller into human clinical trials by the end of next year.

Jnana has raised $50m in a series A round backed by Pfizer and AbbVie to continue development of its protein drug discovery platform.

GV has joined the investors in oncology treatment developer Relay Therapeutics, which has now raised $120m altogether.

The surgical robot spinout from University of Nebraska will use the series B financing, co-led by SinoPharm, to support it through its application for market clearance.

GV has joined the investors in oncology treatment developer Relay Therapeutics, which has now raised $120m altogether.

Remynd could receive as much as $413m from healthcare firm Novo Nordisk if its ReS39 diabetes treatment is proven to be effective.

Koch Disruptive Technologies led the latest round for the ultrasound surgery system developer, which is also backed by GE Healthcare and Elbit Imaging.